Bio-Rad Laboratories (BIO) Goodwill (2009 - 2026)

Bio-Rad Laboratories (BIO) has 18 years of Goodwill data on file, last reported at $577.1 million in Q1 2026.

• On a quarterly basis, Goodwill rose 39.19% year-over-year to $577.1 million in Q1 2026; TTM through Mar 2026 was $577.1 million, a 39.19% increase from a year earlier, with the FY2025 full-year figure at $579.8 million, up 41.24% from the prior year.
• Goodwill for Q1 2026 stood at $577.1 million, roughly flat from $579.8 million in the prior quarter.
• Over the last five years, Goodwill for BIO reached as high as $579.8 million in Q4 2025 and fell as low as $55.9 million in Q3 2022.
• Historically, Goodwill has averaged $403.2 million across 5 years, with a median of $411.5 million in 2023.
• Across the five-year window, Goodwill tumbled 80.85% in 2022 and jumped 628.0% in 2023, its largest moves.
• Year by year, Goodwill stood at $406.5 million in 2022, then increased by 1.75% to $413.6 million in 2023, then retreated by 0.75% to $410.5 million in 2024, then jumped by 41.24% to $579.8 million in 2025, then fell by 0.47% to $577.1 million in 2026.
• Per Business Quant data, the three most recent Goodwill figures were $577.1 million in Q1 2026, $579.8 million in Q4 2025, and $578.7 million in Q3 2025.